Full Text View
Tabular View
No Study Results Posted
Related Studies
A Comparison of Fluoxetine and Divalproex for the Treatment of Intermittent Explosive Disorder
This study is currently recruiting participants.
Study NCT00078754   Information provided by National Institute of Mental Health (NIMH)
First Received: March 5, 2004   Last Updated: February 12, 2008   History of Changes
Related Studies can be found by searching for the Conditions, Interventions, and Sponsors found in this study:
Conditions listed in this trial
Intermittent Explosive Disorder
Additional conditions recognized in this trial
Disease
Impulse Control Disorders
More general conditions related to this trial
Mental Disorders
Pathologic Processes
Interventions listed in this trial
Fluoxetine
Divalproex
Placebo
Additional drug interventions recognized in this trial
Valproic Acid
More general drug interventions related to this trial
Anticonvulsants
Antidepressive Agents
Antidepressive Agents, Second-Generation
Antimanic Agents
Central Nervous System Agents
Central Nervous System Depressants
Enzyme Inhibitors
GABA Agents
Molecular Mechanisms of Pharmacological Action
Neurotransmitter Agents
Neurotransmitter Uptake Inhibitors
Pharmacologic Actions
Physiological Effects of Drugs
Psychotropic Drugs
Serotonin Agents
Serotonin Uptake Inhibitors
Therapeutic Uses
Tranquilizing Agents
Sponsors listed in this trial
National Institute of Mental Health (NIMH)


Contact Help Desk
Lister Hill National Center for Biomedical Communications,  U.S. National Library of Medicine,
U.S. National Institutes of Health,  U.S. Department of Health & Human Services,
USA.gov,  Copyright,  Privacy,  Accessibility,  Freedom of Information Act

U.S. National Institutes of Health U.S. National Library of Medicine U.S. Department of Health & Human Services